Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Qbic Fund is an inter-university venture capital fund based in St-Denijs-Westrem, Belgium, founded in 2012. With an AUM of €190 million, Qbic Fund is dedicated to transforming technological breakthroughs into sustainable businesses. The fund primarily supports spin-offs and start-ups that valorize research from its knowledge partners, which include various Belgian universities and research institutes. This unique positioning allows Qbic Fund to leverage academic insights and innovations, fostering a strong ecosystem for technological advancement.
Since its inception, Qbic Fund has launched multiple funds, including Qbic I, Qbic II, and the ongoing Qbic III, which was launched in 2022. The firm has successfully invested in a total of 18 companies through Qbic I and 19 through Qbic II, with ongoing investments in Qbic III. This track record highlights the firm’s commitment to nurturing early-stage companies and its ability to adapt to the evolving landscape of venture capital.
Qbic Fund is recognized for its collaborative approach, working closely with its knowledge partners to identify promising ventures that align with their research and development goals. This strategy not only enhances the potential for successful investments but also contributes to the broader mission of fostering innovation and sustainability in the business landscape.
Qbic Fund operates as a sector-agnostic seed and early-stage venture capital fund, focusing on investments in companies linked to its knowledge partners. The firm typically participates in the first external investment round, providing essential capital and support to help these companies grow. Qbic Fund's investment strategy is centered around two main categories: knowledge partner spin-offs and start-ups that are closely associated with its academic collaborators.
The fund seeks to invest in innovative companies that demonstrate strong research and development capabilities, particularly those that can leverage technological advancements to create sustainable business models. By focusing on early-stage investments, Qbic Fund aims to support entrepreneurs in their formative stages, helping them navigate the challenges of scaling their businesses while fostering a culture of innovation.
Qbic Fund looks for founders who are deeply connected to their research backgrounds and who possess a clear vision for how their innovations can address real-world challenges. The firm values collaboration and encourages partnerships that can enhance the growth potential of its portfolio companies. This approach not only benefits the companies but also strengthens the ties between academia and industry, paving the way for future technological breakthroughs.
Qbic Fund boasts a diverse portfolio of innovative companies that exemplify its commitment to supporting technological advancements. Notable investments include **AILOS**, which is redefining actuation for next-generation robotics, and **Innocens**, which is developing AI-powered alerts for patient deterioration. Another significant investment is **Spica Therapeutics**, known for pioneering macrophage-subset targeted therapies.
Other key portfolio companies include **eyeo**, which is developing breakthrough color-splitting photonics for high-performance imaging, and **Rainbow Crops**, which combines genome editing and precision breeding for climate-resilient crops. Additionally, **Pleevi** provides AI-driven smart charging solutions for electric vehicles, while **Tanai Therapeutics** is focused on developing an oral therapeutic for obesity.
Furthermore, **Flindr** aims to restore immune response to cancer, and **VoxelSensors** is developing ultra-low power 3D perception sensors for Extended Reality. Lastly, **Animab** is working on developing antibodies for gastrointestinal pathogens in livestock. This diverse array of companies highlights Qbic Fund's commitment to fostering innovation across various sectors and its strategic focus on R&D collaborations.
To pitch Qbic Fund, founders should email their proposals to info@qbic.be. It is recommended to include a clear overview of the business model and how it aligns with the fund's focus on R&D collaborations and technological innovations.
Qbic Fund primarily invests in the pre-seed and seed stages of company development. The firm typically participates in the first external investment round, providing essential capital to help startups establish their business models and begin their growth journey.
Founders interested in pitching to Qbic Fund can reach out via email at info@qbic.be. It is advisable to provide a clear overview of the business model, the technological innovation, and how the startup aligns with Qbic Fund's focus on R&D collaborations.
Qbic Fund is sector-agnostic, meaning it does not limit its investments to specific industries. Instead, it focuses on companies linked to its knowledge partners, which can span various sectors, particularly those that emphasize technological innovation and sustainability.
The specific check size for investments by Qbic Fund is not detailed in the provided information. However, as a seed and early-stage investor, it typically provides funding that aligns with the needs of startups in their initial growth phases.
Qbic Fund primarily invests in Europe, focusing on startups and spin-offs that are connected to its knowledge partners, which include various Belgian universities and research institutes.
To apply for funding from Qbic Fund, founders should prepare a comprehensive pitch that outlines their business model and technological innovations. They can submit their pitch via email at info@qbic.be. The firm encourages clear communication of how the startup aligns with their investment focus.
While specific details on portfolio support are not provided, Qbic Fund is known for its ongoing support throughout the growth of its portfolio companies. This includes leveraging its network of knowledge partners to facilitate R&D collaborations and enhance business development opportunities.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.